key: cord-0809344-nj7prvvj
authors: Roncati, Luca; Ligabue, Giulia; Fabbiani, Luca; Malagoli, Claudia; Gallo, Graziana; Lusenti, Beatrice; Nasillo, Vincenzo; Manenti, Antonio; Maiorana, Antonio
title: Type 3 hypersensitivity in COVID-19 vasculitis
date: 2020-05-29
journal: Clin Immunol
DOI: 10.1016/j.clim.2020.108487
sha: 474e12e66c6210b9b692365e7bd439a421012fb6
doc_id: 809344
cord_uid: nj7prvvj

Coronavirus Disease 2019 (COVID-19) is an ongoing public health emergency and new knowledge about its immunopathogenic mechanisms is deemed necessary in the attempt to reduce the death burden around the world. For the first time in worldwide literature, we provide scientific evidence that in COVID-19 vasculitis a life-threatening escalation from type 2 T-helper immune response (humoral immunity) to type 3 hypersensitivity (immune complex disease) takes place. The subsequent deposition of immune complexes inside the vascular walls is supposed to induce a severe inflammatory state and a cytokine release syndrome, whose interleukin-6 is the key myokine, from the smooth muscle cells of blood vessels.

slight excess of soluble antigens lead to the accumulation of immune complexes, not enough cleared from the circulation by the innate immune system [5] . These antigen-antibody complexes precipitate inside the tissues, in particular blood vessels, inducing a severe inflammatory state by the action of complement anaphylatoxins (C3a and C5a), which in turn stimulate the release of histamine from mast cells and the recruitment of phagocytes, in primis neutrophils, the main responsible for the tissue damage [5] . On histopathology, the result of this process inside the walls of blood vessels is depicted by an acute necrotizing vasculitis with neutrophilic infiltration, karyorrhexis and fibrinoid necrosis, the so called «leukocytoclastic vasculitis» (LCV), also reported in the English medical literature by the term «hypersensitivity vasculitis» [6] ; platelet aggregation correlates with hypercoagulability and thrombosis, disorders described in course of COVID-19, too [7] . The just mentioned fibrinoid necrosis represents a specific pattern of tissue injury, which occurs once antigen-antibody complexes are deposited in the walls of blood vessels along with fibrin and complement anaphylatoxins; therefore, it can be considered a diagnostic clue of immune-mediated vasculitides from type 3 hypersensitivity [8] . LCV is preceded by a viral infection, such as hepatitis B, hepatitis C and HIV, in a relevant percentage of cases [6] . The onset time of type 3 hypersensitivity varies from days to weeks depending on the presence or not of memory cells against the precipitating antigen; clinical features emerge approximately 10 days after initial antigenic challenge [8] . During the Severe Acute Respiratory Syndrome (SARS) outbreak in 2002-2003, caused by SARS-CoV-2 predecessor (SARS-CoV), it was observed that the acute respiratory distress syndrome, one the most serious complications of the disease, significantly overlapped with antiviral immunoglobulin G (IgG) seroconversion [9] ; besides, it was found that patients who developed more quickly the anti-spike neutralizing antibody showed a higher risk of dying from the disease [10] . Translating our current findings on COVID-19, these alarming data can be now explained by a life-threatening escalation from T h 2 immune response to type 3 hypersensitivity with the subsequent deposition of antigen-antibody complexes, particularly inside the walls of blood vessels, to such an extent as to generate a systemic vasculitis in the context of an immune complex J o u r n a l P r e -p r o o f disease (Fig. 1) . Preexisting endothelial dysfunctions due to atherosclerosis could worsen the deposition process in elderly and middle-aged patients [11] ; since the smooth muscle cells in tunica media of blood vessels are able to produce interleukin-6 (IL-6) [12], a key myokine of inflammation and of the cytokine release syndrome, their inflammatory involvement can justify well the described «cytokine storm» in COVID-19 critical patients, a dramatic phenomenon remained not fully elucidated up to date. 

Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2

Type 1/Type 2 immunity in infectious diseases

What about the original antigenic sin of the humans versus SARS-CoV-2?

Signals of T h 2 immune response from COVID-19 patients requiring intensive care

Immunobiology: the immune system in health and disease

Leukocytoclastic vasculitis

Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action

Robbins basic pathology

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals

Vasculitis: mechanisms involved and clinical manifestations

We thank the Interdepartmental Center for Large Instruments of Modena and Reggio Emilia University, the Pathology Lab of Polyclinic Hospital and, in particular, Giuliana Pagliani for her assistance in acquiring photographic images.

None of the authors has any financial conflict of interest to disclose